Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surrozen (SRZN) Cash & Equivalents (2021 - 2025)

Surrozen has reported Cash & Equivalents over the past 5 years, most recently at $89.2 million for Q4 2025.

  • Quarterly results put Cash & Equivalents at $89.2 million for Q4 2025, up 158.06% from a year ago — trailing twelve months through Dec 2025 was $89.2 million (up 158.06% YoY), and the annual figure for FY2025 was $89.2 million, up 158.06%.
  • Cash & Equivalents for Q4 2025 was $89.2 million at Surrozen, up from $81.3 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for SRZN hit a ceiling of $101.6 million in Q1 2025 and a floor of $14.3 million in Q1 2022.
  • Median Cash & Equivalents over the past 5 years was $33.5 million (2021), compared with a mean of $42.3 million.
  • Biggest five-year swings in Cash & Equivalents: plummeted 58.21% in 2022 and later soared 272.46% in 2025.
  • Surrozen's Cash & Equivalents stood at $33.1 million in 2021, then decreased by 25.39% to $24.7 million in 2022, then surged by 45.98% to $36.0 million in 2023, then fell by 4.1% to $34.6 million in 2024, then surged by 158.06% to $89.2 million in 2025.
  • The last three reported values for Cash & Equivalents were $89.2 million (Q4 2025), $81.3 million (Q3 2025), and $90.4 million (Q2 2025) per Business Quant data.